2139. Immunogenicity, reactogenicity and safety of a Respiratory Syncytial Virus prefusion F (RSVPreF3) candidate vaccine co-administered with the seasonal quadrivalent influenza vaccine in older adults

BACKGROUND: Respiratory syncytial virus (RSV) can cause severe respiratory disease in older adults (OAs). However, there is no approved vaccine against RSV disease in OAs. Co-administration of vaccines against RSV and influenza could be considered given their overlapping seasonality. Here, we assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandler, Reynaldo, Montenegro, Nathali, Llorach, Cecilia, Quinn, Dean, Noriega-Aguirre, Lorena, Bensellam, Mohammed, De Schrevel, Nathalie, Kuriyakose, Sherine, Lambert, Axel, Olivier, Aurélie, Hulstrøm, Veronica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752441/
http://dx.doi.org/10.1093/ofid/ofac492.1759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752441/
http://dx.doi.org/10.1093/ofid/ofac492.1759

Ejemplares similares